Alibaba Health Information Technology (HKG:0241) recorded a rise in attributable profit for the year ended March 31 to 1.43 billion yuan from 883.5 million yuan a year prior, a Monday filing with the Hong Kong bourse said.
Earnings per share stood at 0.0888 yuan for the year, down from 0.0627 yuan in the corresponding period of the last fiscal year.
Revenue for the internet solutions provider for the medical and pharmaceutical sector rose by 13% to 30.6 billion yuan in the period from 27 billion yuan a year prior.
The higher revenue was mainly due to the steady development of the pharmaceutical direct sales and ecommerce platform businesses.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。